Last updated:
ID:
84103
Start date:
20 September 2022
Project status:
Current
Principal investigator:
Dr Farshad Farshidfar
Lead institution:
Tenaya Therapeutics Inc., United States of America

Tenaya Therapeutics is a biopharmaceutical company working on discovery of new treatments for heart disease. We will look at genetic causes of heart failure, the genetic causes of how the heart functions, and integrate this with clinical data to find new relationships between genes and heart disease. We will use this information to create new ways of treating heart disease.

Related publications

Author(s)
Luke Zhang, Prachi Kulkarni, Farshad Farshidfar, Whit Tingley, Tim Hoey, Whedy Wang, James R. Priest, Sylwia M. Figarska
Journal
BMC Cardiovascular Disorders
  • heart and blood vessels

All publications